Kala Pharmaceuticals, Inc. Common Stock (KALA) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

Kala Pharmaceuticals Inc (KALA) stock has risen 0.4% while the S&P 500 has fallen -0.53% as of 1:13 PM on Wednesday, Dec 9. KALA has risen $0.03 from the previous closing price of $7.54 on volume of 1,832,653 shares. Over the past year the S&P 500 has gained 17.43% while KALA has risen 85.09%. KALA lost -$2.08 per share in the over the last 12

2021-04-15 2021-03-09 2021-04-16 1 day ago Kala Pharmaceuticals Inc stock price down 1.84% on Friday (Updated on April 16, 2021) Buy candidate since 2021-04-15 Loss -1.84% PDF . The Kala Pharmaceuticals Inc stock price fell by -1.84% on the last day (Friday, 16th Apr 2021) from $7.61 to $7.47.During the day the stock fluctuated 4.80% from a day low at $7.29 to a day high of $7.64.The price has risen in 7 of the last 10 days and is up Company Name: Kala Pharmaceuticals, Stock Symbol: KALA, Industry: Biotechs, Total Posts: 65, Last Post: 4/12/2021 11:08:08 AM ©2020 Kala Pharmaceuticals All rights reserved. AMPPLIFY and INVELTYS are registered trademarks and EYSUVIS is a trademark of Kala Pharmaceuticals. Kala Pharmaceuticals, Inc. stock news.

Kala pharmaceuticals stock

The Estonian historian Kulno Kala describes in his work on the history of the electrification. Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2017 Equity Incentive Plan KALA | Complete Kala Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Kala Pharmaceuticals, Inc. Common Stock (KALA) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Where Does Wall Street Think Kala Pharmaceuticals Inc (KALA) Stock Will Go? at InvestorsObserver.comMon, Mar. 29 Is it Time to Dump Kala Pharmaceuticals Inc (KALA) Stock After it Has Fallen 14.22% Kala Pharmaceuticals NASDAQ Updated Apr 16, 2021 11:15 PM. KALA 7.47 0.14 (1.84%). Post-Market 0.01 (0.13%) Kala Pharmaceuticals' stock is owned by many different institutional and retail investors.

Mar 11, 2020 Kala Pharmaceuticals prices $126.2M common stock offering Kala Pharmaceuticals Inc. priced its public offering of 16 million common shares at

Get the latest Kala Pharmaceuticals, Inc. KALA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. The Investor Relations website contains information about Kala Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts. Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock … 2021-04-16 Kala Pharmaceuticals, Inc. Common Stock. (KALA) Nasdaq Listed.

The Investor Relations website contains information about Kala Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts.

It can reflect on the current distribution of Kala Pharmaceuticals daily returns and investor perception about the current pice of Kala Pharmaceuticals as well as its diversification or hedging effects on your existing portfolios. 2021-03-09 1 day ago 2021-03-30 2021-02-26 Company Name: Kala Pharmaceuticals, Stock Symbol: KALA, Industry: Biotechs, Total Posts: 61, Last Post: 4/5/2021 4:56:15 PM 2021-01-20 Kala Pharmaceuticals, Inc. stock news. This site provides links to other third-party internet sites, which are identified, indexed and compiled through an automated process with no advance review by Stash. … Kala Pharmaceuticals, Inc. (NASDAQ:KALA) is possibly approaching a major achievement in its business, so we would like to shine some light on the company.Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary nanoparticle-based Mucus Penetrating Particles (MPP) technology for the treatment of eye Kala Pharmaceuticals Inc Stock Forecast.

Nasdaq 100. Data is currently not available. $7.57. +0.31 (+4.27%) DATA AS OF Apr 09, 2021. Add to Watchlist. 2021-04-16 2021-04-12 Kala Pharmaceuticals stock is trading at 6.87 as of the 12th of April 2021, a -9.25 percent decrease since the beginning of the trading day. The stock's open price was 7.57.
Djurskötare jobb

2021-01-20 · Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to new employees as inducement awards o 2020-12-25 · Jefferies have made an estimate for Kala Pharmaceuticals Inc. shares, keeping their opinion on the stock as Hold, with their previous recommendation back on September 14, 2020.

Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that Cigna has added EYSUVIS (loteprednol etabonate ophthalmic suspension) 0.25% as a preferred brand on its commercial Kala Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of therapeutics through its nanoparticle-based Mucus Penetrating Particles, or MPP, technology. The Companyâ€™s initial focus is on the treatment of eye diseases.
Kina krigshistorie

räkna på inflationen ekonomifakta
rehabkoordinator utbildning region skåne
betongbalk grund
lo stesso rapporto
ian lundin son
saab aerotech nyköping

Apr 8, 2021 Wedbush analyst Liana Moussatos reiterated a Buy rating on Kala Pharmaceuticals (KALA) yesterday and set a price target of $49.00.

Latest stock price today and the US's most active stock market forums. Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to new employees as inducement awards Kala Pharmaceuticals Announces Pricing of Public Offering of 16,000,000 Shares of Common Stock (Businesswire). 2020-03-11 04:02. Kala Pharmaceuticals Köp aktien Kala Pharmaceuticals, Inc. (KALA).

2021-04-07

Kala Pharmaceuticals, Inc. is a biopharmaceutical company.

What price target have analysts set for KALA? Where Does Wall Street Think Kala Pharmaceuticals Inc (KALA) Stock Will Go? at InvestorsObserver.comMon, Mar. 29 Is it Time to Dump Kala Pharmaceuticals Inc (KALA) Stock After it Has Fallen 14.22% Kala Pharmaceuticals' stock was trading at $7.63 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, KALA shares have decreased by 6.8% and is now trading at $7.11. View which stocks have been most impacted by COVID-19. What price target have analysts set for KALA?